Stand tall, hum and try a dead hang: 22 two minute tension relievers

Feeling a little… tense? From the top of your head down to the soles of your feet, here are lots of quick ways to soothe stressRestore a feeling of calm by scrunching your shoulders up to your ears

Journalists Wrap Up 2024 With Topics From Trump 2.0 to Frustration With Health Industry

KFF Health News staff made the rounds on national and local media in the last two weeks to discuss topical stories. Here’s a collection of their appearances.

Can I survive for 24 hours without GPS navigation?

Spatial memory is a use-it-or-lose it commodity, so I gave life without Google Maps a tryTaxi and ambulance drivers are less likely than other workers to die of Alzheimer’s disease, according to a H

Democrats highlight a casualty of the spending fight: funding to combat pediatric cancer.

House passes slimmed-down spending bill to keep government open

Lawmakers were unable to accomplish any health care goals this Congress beyond the status quo.

Next-in-Class Once-Daily Pill Approved for Cystic Fibrosis

(MedPage Today) -- The FDA approved a once-daily oral combination of vanzacaftor/tezacaftor/deutivacaftor (Alyftrek) for cystic fibrosis (CF) in adults and children 6 years and up, drugmaker Vertex P

FDA Approves First Sleep Apnea Drug

(MedPage Today) -- The FDA approved tirzepatide (Zepbound) for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity, the agency announced late Friday.

In Settling Fraud Case, New York Medicare Advantage Insurer, CEO Will Pay up to $100M

A whistleblower suit alleged a health insurer bilked Medicare by exaggerating how sick patients were.

International court rules against El Salvador in key abortion rights case

Court finds Central American country violated rights of a pregnant woman who was denied an abortion in 2013The Inter-American Court of Human Rights (IACHR) has ruled that El Salvador violated the huma

FDA OKs Bioengineered Vessel to Reduce Limb Amputations After Vascular Trauma

(MedPage Today) -- The FDA on Friday approved acellular tissue engineered vessel (Symvess), an off-the-shelf product for treating vascular trauma in the extremities of adults.